联合尿mAlB、CysC及SCr检查在慢性肾病的临床应用研究  

Clinical Application of Combined Urinary m AlB, Cys C and SCr in Chronic Kidney Disease

作　　者：解娟[1] 范云[1] 刘文康[1] 闫福堂[1] 袁军[1] Xie Juan Fan Yun Liu Wen-kang et al(Department of Laboratory Medicine, Shanxi Provincial People ＇s Hospital,Xi’an 710068, China)

机构地区：[1]陕西省人民医院检验科,西安710068

出　　处：《中国医药导刊》2016年第11期1161-1162,共2页Chinese Journal of Medicinal Guide

摘　　要：目的:探讨联合尿微量白蛋白(m Al B)、血清胱抑素C(Cys C)及血肌酐(SCr)检查在慢性肾脏病(CHK)的临床应用。方法:73例CHK患者采用罗氏C702全自动生化仪分别检测尿微量白蛋白,血清胱抑素C及血肌酐。结果:m Al B、SCr、Cys C阳性标本例数分别为48例、38例、57例,阳性检出率分别为66%、52%、78%。三个组别三个项目单因素方差分析结果,两两比较显示,除SCr检验结果的肾功能正常组和轻到中度损害,两个组别的结果无差异,其余结果均有统计学意义。结论:联合m Al B、Cys C及SCr、检查在CHK的诊断中具有较高的临床应用价值。Objective： To investigate the combined urinary albumin（m Al B）, serum cystatin C（Cys C） and serum creatinine（SCr） examination in patients with chronic kidney disease（CHK） clinical application. Methods： 73 cases of CHK patients with microalbuminuria were detected by Roche C702 automatic biochemical analyzer, serum cystatin C and serum creatinine. Results：m Al B, SCr, Cys C positive samples were 48 cases, 38 cases, 57 cases, positive detection rate was 66%, 52%, 78%. The analysis results of three groups of three single factor variance, 22 comparison showed that in addition to the SCr test results of normal renal function group and mild to moderate damage, there is no difference between the two groups of results, the results were statistically significant. Conclusion： Combined with m Al B, Cys C and SCr, the examination in the diagnosis of CHK has high clinical application value.

关 键 词：尿微量白蛋白 血清胱抑素C 血肌酐 慢性肾脏病 

分 类 号：R692[医药卫生—泌尿科学] R446.1[医药卫生—外科学]